RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS
New Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth
Read MoreBlog
Welcome to our Blog, where you can stay up to date with all the latest from RLS
Radiopharmacies. You will find company news and articles providing exclusive insights
into what's happening within the radiopharmaceutical industry.
Blogs
SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost
Marks Latest Step in RLS Expansion into Oncology & Work to Create an Unbroken Chain of Patient Care from Clinical Trial to Commercial Supply
Read MoreRLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.
LAKE ZURICH, IL., June 5, 2023 /PRNewswire/ — RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc, a leading healthcare improvement company headquartered in Charlotte, North Carolina. […]
Read MoreRLS & Evergreen Partnership for Drug Candidate OCTEVY™
Expands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen
Read MoreQSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam
Partnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S.
Read MoreRls Names Radiopharmacy and Healthcare Leader Trey Bankson as New Chief Operating Officer
Bankson’s Appointment Marks the Latest in Recent Slate of Executive Hires to Position RLS for Long-Term, Sustainable Growth and Success.
Read More